Hear the pros and cons from surgeons who have transitioned from training to their first job at the same institution, and at a different institution. Panelists will also discuss what role your division chief plays during this important transition.
Circulating tumor DNA (ctDNA) is a blood test that can be used to detect and monitor thoracic malignancies. It is being used to detect mutations, monitor for recurrence after surgery and other treatments, and can even be used in conjunction with screening to help identify malignancy. As the field continues to advance, it is crucial for thoracic surgeons, trainees, and healthcare providers to stay informed about the latest developments in ctDNA testing and its applications for thoracic patients.
The latest techniques and management strategies in cardiovascular and thoracic critical care and enhanced recovery after surgery for the entire care team.
Learn how to take advantage of everything the STS Annual Meeting has to offer, from educational sessions and networking opportunities. Special focus will be given to trainees and first-time attendees.
The premier annual event in cardiothoracic surgery, unveiling never-before-seen science, techniques, and technology, and creating a forum to build lasting connections with colleagues.
A panel of leaders in cardiothoracic surgery will explore the cost of patient safety relative to the effects on education, how public reporting of patient safety is often confusing to patients, and how expected patient safety results may lead to disproportionate investments and difficult prioritization decisions.
